X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6481) 6481
Publication (530) 530
Book Review (38) 38
Book Chapter (11) 11
Magazine Article (8) 8
Conference Proceeding (5) 5
Web Resource (5) 5
Book / eBook (4) 4
Paper (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
triazines - pharmacology (3775) 3775
animals (3237) 3237
humans (2669) 2669
male (2020) 2020
index medicus (2012) 2012
pharmacology & pharmacy (1480) 1480
rats (1383) 1383
female (1217) 1217
mice (1011) 1011
triazines - therapeutic use (952) 952
triazines - chemistry (942) 942
lamotrigine (836) 836
dose-response relationship, drug (745) 745
chemistry, medicinal (686) 686
triazines - chemical synthesis (681) 681
adult (641) 641
structure-activity relationship (565) 565
biochemistry & molecular biology (560) 560
triazines - administration & dosage (497) 497
triazines (485) 485
triazines - pharmacokinetics (448) 448
neurosciences (427) 427
middle aged (426) 426
antineoplastic agents - pharmacology (424) 424
in vitro techniques (422) 422
triazines - metabolism (408) 408
anticonvulsants - pharmacology (404) 404
anticonvulsants - therapeutic use (402) 402
analysis (387) 387
clinical neurology (369) 369
toxicology (363) 363
epilepsy (362) 362
time factors (360) 360
triazines - adverse effects (357) 357
molecular structure (354) 354
rats, sprague-dawley (343) 343
kinetics (334) 334
triazoles - pharmacology (326) 326
rats, wistar (320) 320
imidazoles - pharmacology (302) 302
drug interactions (297) 297
oncology (295) 295
cell line, tumor (292) 292
epilepsy - drug therapy (285) 285
triazines - blood (274) 274
antiepileptic drugs (269) 269
vardenafil dihydrochloride (263) 263
enzyme inhibitors - pharmacology (258) 258
adolescent (257) 257
triazines - toxicity (251) 251
psychiatry (249) 249
anticonvulsants (244) 244
cells, cultured (240) 240
treatment outcome (240) 240
piperazines - pharmacology (239) 239
chemistry, organic (238) 238
in-vitro (237) 237
pharmacokinetics (234) 234
models, molecular (230) 230
cancer (229) 229
research (226) 226
chemistry, multidisciplinary (225) 225
disease models, animal (217) 217
cell line (216) 216
aged (207) 207
chemistry (207) 207
herbicides - pharmacology (205) 205
anticonvulsants - adverse effects (204) 204
pharmacology (204) 204
drug therapy, combination (203) 203
carbamazepine (200) 200
derivatives (200) 200
binding sites (199) 199
double-blind (197) 197
triazine (196) 196
inhibitors (190) 190
cell survival - drug effects (188) 188
expression (186) 186
child (182) 182
article (180) 180
inhibition (179) 179
administration, oral (178) 178
research article (178) 178
drugs (177) 177
toxicity (177) 177
anticonvulsants - pharmacokinetics (175) 175
drug design (173) 173
drug resistance (169) 169
efficacy (168) 168
adenosine - pharmacology (167) 167
pyrimidines - pharmacology (165) 165
apoptosis (164) 164
chemical phenomena (162) 162
anticonvulsants - administration & dosage (160) 160
cell proliferation - drug effects (159) 159
microbial sensitivity tests (159) 159
sulfones - pharmacology (158) 158
cell biology (155) 155
ligands (155) 155
drug synergism (154) 154
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6088) 6088
German (141) 141
Russian (81) 81
Japanese (66) 66
French (51) 51
Chinese (20) 20
Italian (14) 14
Polish (14) 14
Czech (10) 10
Ukrainian (7) 7
Spanish (6) 6
Danish (2) 2
Hungarian (2) 2
Portuguese (2) 2
Slovak (2) 2
Croatian (1) 1
Dutch (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 1, pp. R23 - R32
The interaction between adenosine and soluble epoxide hydrolase (sEH) in vascular response is not known. Therefore, we hypothesized that lack of sEH in mice... 
Relaxation | CYP2J5-epoxgenase;ω-hydroxylase | receptor | Soluble epoxide hydrolase | Contraction | Adenosine A | Epoxide Hydrolases - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Butyrates - pharmacology | Male | Receptor, Adenosine A2A - physiology | Lauric Acids - pharmacology | Vasodilation - genetics | 8,11,14-Eicosatrienoic Acid - analogs & derivatives | Adenosine A2 Receptor Agonists - pharmacology | Urea - analogs & derivatives | Female | Benzamides - pharmacology | Oxygenases - physiology | Vasodilation - physiology | 8,11,14-Eicosatrienoic Acid - pharmacology | Adamantane - analogs & derivatives | NG-Nitroarginine Methyl Ester - pharmacology | Adamantane - pharmacology | Triazines - pharmacology | Phenethylamines - pharmacology | Vasodilator Agents - pharmacology | Enzyme Inhibitors - pharmacology | Gene Silencing | Adenosine - pharmacology | Pyrimidines - pharmacology | Epoxide Hydrolases - genetics | Triazoles - pharmacology | Adenosine A2 Receptor Antagonists - pharmacology | PPAR gamma - physiology | Animals | Adenosine - analogs & derivatives | Benzoates - pharmacology | Mice | Phenylurea Compounds - pharmacology | Pyridines - pharmacology | Vasodilation - drug effects | Urea - pharmacology | adenosine A2a receptor | CYP2J5-epoxgenase | ω-hydroxylase | relaxation | contraction | Cardiovascular and Renal Integration | soluble epoxide hydrolase | adenosine A1 receptor
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 7/2011, Volume 384, Issue 1, pp. 47 - 57
In epilepsy, allegedly, a neurotransmitter imbalance between the inhibitory GABA and the excitatory glutamate prevails. Therefore, some antiepileptic drugs... 
Neurosciences | Veratridine | Biomedicine | Epilepsy | GABA | Neocortical synaptosomes | Pharmacology/Toxicology | Antiepileptic drugs | Potassium | ACTION-POTENTIALS | VOLTAGE-DEPENDENT LIMITATION | TEMPORAL-LOBE EPILEPSY | NEUROTRANSMITTER RELEASE | VALPROIC ACID | TRANSPORTER GAT-1 | MOUSE CENTRAL NEURONS | IN-VITRO | SODIUM VALPROATE | PHARMACOLOGY & PHARMACY | CALCIUM-CHANNEL | Synaptosomes - drug effects | Rats, Wistar | gamma-Aminobutyric Acid - metabolism | Humans | Middle Aged | Child, Preschool | Infant | Male | Pregabalin | Synaptosomes - metabolism | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Calcium - deficiency | Young Adult | Calcium - antagonists & inhibitors | Neocortex - metabolism | Neocortex - drug effects | Piracetam - pharmacology | Adult | Female | Phenytoin - pharmacology | Tetrodotoxin - pharmacology | Nipecotic Acids - pharmacology | Child | Carbamazepine - pharmacology | Triazines - pharmacology | Rats | gamma-Aminobutyric Acid - pharmacology | Tetanus Toxin - pharmacology | Potassium - pharmacology | Veratridine - pharmacology | GABA Antagonists - pharmacology | Animals | Cyclohexanecarboxylic Acids - pharmacology | Piracetam - analogs & derivatives | Adolescent | Oximes - pharmacology | Aged | gamma-Aminobutyric Acid - analogs & derivatives | Amines - pharmacology | Phenytoin - pharmacokinetics | Drugs | Brain | Anticonvulsants | Marine toxins | Neurons | Tetanus | Glutamate | Sodium channels | gamma -Aminobutyric acid | Calcium | lamotrigine | Cortex | veratridine | tetanus toxin | Antiepileptic agents | Exocytosis | Valproic acid | Etiracetam | Carbamazepine | Depolarization | Neurotransmitters | Neural networks | gabapentin | Synaptosomes | Phenytoin
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 03/2013, Volume 24, Issue 3, pp. 251 - 259
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 12/2012, Volume 9, Issue 12, pp. 3028 - 3040
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 04/2010, Volume 113, Issue 2, pp. 530 - 542
J. Neurochem. (2010) 113, 530–542. Adenosine produces cardiovascular depressor effects in various brain regions. However, the cellular mechanisms underlying... 
KATP | synaptic transmission | G proteins | sympathetic nervous system | hypothalamus | adenosine receptors | Adenosine receptors | Hypothalamus | Sympathetic nervous system | Synaptic transmission | SUPRAOPTIC NUCLEUS | PRESYNAPTIC INHIBITION | SPONTANEOUSLY HYPERTENSIVE-RATS | SENSITIVE K+ CHANNELS | RECEPTOR AGONISTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | SPINAL-CORD | K-ATP | NEUROSCIENCES | SIGNALING PATHWAY | ENDOGENOUS ADENOSINE | CENTRAL-NERVOUS-SYSTEM | SYNAPTIC GABA RELEASE | Analgesics - pharmacology | Tolbutamide - pharmacology | KATP Channels - physiology | Male | Xanthines - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Patch-Clamp Techniques - methods | Dose-Response Relationship, Drug | Paraventricular Hypothalamic Nucleus - cytology | Glyburide - pharmacology | 6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology | Tetrodotoxin - pharmacology | Neurons - drug effects | Action Potentials - drug effects | Potassium Channel Blockers - pharmacology | Guanosine Diphosphate - pharmacology | Membrane Potentials - drug effects | Triazines - pharmacology | Rats | Sodium Channel Blockers - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Adenosine - pharmacology | Bicuculline - pharmacology | Thionucleotides - pharmacology | Membrane Potentials - physiology | Rats, Sprague-Dawley | Receptor, Adenosine A1 - metabolism | GABA Antagonists - pharmacology | Triazoles - pharmacology | Animals | Guanosine Diphosphate - analogs & derivatives | In Vitro Techniques | Cell research | Adenosine | Neurons | Tolbutamide | GABA | Glibenclamide | Cytochemistry | Membrane proteins | Cardiovascular disease | Potassium | Adenosine triphosphatase
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 06/2011, Volume 660, Issue 2-3, pp. 394 - 401
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 05/2004, Volume 19, Issue 9, pp. 2464 - 2474
A major subtype of glutamate receptors, AMPA receptors (AMPARs), are generally thought to mediate excitation at mammalian central synapses via the ionotropic... 
presynaptic inhibition | rat | GABAergic inhibitory synapse | AMPA‐type glutamate receptor | cerebellum | Cerebellum | Presynaptic inhibition | AMPA-type glutamate receptor | Rat | Glycine - analogs & derivatives | Rats, Wistar | Calcium - metabolism | gamma-Aminobutyric Acid - metabolism | Benzoxazines | Neural Inhibition - physiology | Drug Interactions | Piperidines - pharmacology | Egtazic Acid - analogs & derivatives | Neurons - physiology | Neurons - drug effects | Action Potentials - drug effects | Ryanodine - pharmacology | Cyclopropanes - pharmacology | Pyrazoles - pharmacology | Synapses - drug effects | Triazines - pharmacology | Presynaptic Terminals - drug effects | Receptors, AMPA - physiology | Colforsin - pharmacology | Synapses - physiology | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Rats | Excitatory Amino Acid Agonists - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Presynaptic Terminals - physiology | Chelating Agents - pharmacology | Calcium Channel Blockers - pharmacology | Benzothiadiazines - pharmacology | GABA Antagonists - pharmacology | Naphthalenes - pharmacology | Triazoles - pharmacology | Animals | Egtazic Acid - pharmacology | Glycine - pharmacology | Cerebellum - cytology | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacology | In Vitro Techniques | Neural Inhibition - drug effects | Receptors, AMPA - drug effects
Journal Article
Neuroscience Letters, ISSN 0304-3940, 01/2003, Volume 335, Issue 3, pp. 167 - 170
Some anticonvulsants show neuroprotective effects, and may be of use in reducing neuronal death resulting from stroke or traumatic brain injury. Here I report... 
Oxygen/glucose deprivation | Hippocampal slice cultures | Neuroprotection | Anticonvulsants | OXYGEN | INHIBITION | IN-VITRO ISCHEMIA | neuroprotection | DRUGS | hippocampal slice cultures | oxygen/glucose deprivation | GLUCOSE DEPRIVATION | anticonvulsants | NEUROSCIENCES | DAMAGE | Phenobarbital - pharmacology | Hypoxia - drug therapy | Amines | Felbamate | Gabapentin | Rats, Wistar | Phenylcarbamates | Anticonvulsants - administration & dosage | Hippocampus - drug effects | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Hypoxia - metabolism | Dose-Response Relationship, Drug | Oxcarbazepine | Tiagabine | Neuroprotective Agents - pharmacology | Piracetam - pharmacology | Phenytoin - pharmacology | Chlordiazepoxide - pharmacology | Neurons - metabolism | Cell Death - drug effects | Neurons - drug effects | Neuroprotective Agents - administration & dosage | Nipecotic Acids - pharmacology | Carbamates - pharmacology | Propylene Glycols - pharmacology | gamma-Aminobutyric Acid | Carbamazepine - pharmacology | Triazines - pharmacology | Carbamazepine - analogs & derivatives | Cells, Cultured | Ischemia - metabolism | Rats | Hippocampus - cytology | Glucose - deficiency | Hippocampus - metabolism | Animals | Ischemia - drug therapy | Piracetam - analogs & derivatives | Phenylenediamines - pharmacology | Acetates - pharmacology | Cyclohexanecarboxylic Acids | Ethosuximide - pharmacology | Midazolam - pharmacology | Lamotrigine | Levetiracetam | Brain | Cell death | Injuries | Stroke (Disease)
Journal Article
Journal Article